TPP2
Basic information
Region (hg38): 13:102596958-102679958
Links
Phenotypes
GenCC
Source:
- autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome (Supportive), mode of inheritance: AR
- immunodeficiency 78 with autoimmunity and developmental delay (Moderate), mode of inheritance: AR
- immunodeficiency 78 with autoimmunity and developmental delay (Strong), mode of inheritance: AR
- immunodeficiency 78 with autoimmunity and developmental delay (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Immunodeficiency 78 with autoimmunity and developmental delay | AR | Allergy/Immunology/Infectious | Among other findings, the condition can involve early-onset immunodeficiency, with severe and recurrent infections, and awareness may allow preventative measures and early and aggressive treatment of infections; BMT has been described | Allergy/Immunology/Infectious; Hematologic; Neurologic | 25525876; 25414442; 33586135 |
ClinVar
This is a list of variants' phenotypes submitted to
- Evans_syndrome,_immunodeficiency,_and_premature_immunosenescence_associated_with_tripeptidyl-peptidase_II_deficiency (665 variants)
- Inborn_genetic_diseases (97 variants)
- not_provided (23 variants)
- Immunodeficiency_78_with_autoimmunity_and_developmental_delay (15 variants)
- TPP2-related_disorder (14 variants)
- not_specified (2 variants)
- Recurrent_lower_respiratory_tract_infections (1 variants)
- Thrombocytopenia (1 variants)
- Global_developmental_delay (1 variants)
- Recurrent_upper_respiratory_tract_infections (1 variants)
- See_cases (1 variants)
- Acute_otitis_media (1 variants)
- Cutis_marmorata (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TPP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001330588.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 216 | 228 | ||||
| missense | 287 | 296 | ||||
| nonsense | 7 | |||||
| start loss | 0 | |||||
| frameshift | 7 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 13 | 4 | 293 | 222 | 8 |
Highest pathogenic variant AF is 0.000006571425
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TPP2 | protein_coding | protein_coding | ENST00000376065 | 29 | 82169 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.999 | 0.000883 | 125724 | 0 | 24 | 125748 | 0.0000954 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.86 | 374 | 651 | 0.574 | 0.0000323 | 8156 |
| Missense in Polyphen | 76 | 226.53 | 0.33549 | 2790 | ||
| Synonymous | -0.389 | 245 | 237 | 1.03 | 0.0000128 | 2380 |
| Loss of Function | 6.28 | 10 | 64.4 | 0.155 | 0.00000323 | 841 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000193 | 0.000183 |
| Ashkenazi Jewish | 0.000300 | 0.000298 |
| East Asian | 0.000112 | 0.000109 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.0000981 | 0.0000967 |
| Middle Eastern | 0.000112 | 0.000109 |
| South Asian | 0.0000657 | 0.0000653 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the proteolytic cascade acting downstream of the 26S proteasome in the ubiquitin-proteasome pathway. May be able to complement the 26S proteasome function to some extent under conditions in which the latter is inhibited. Stimulates adipogenesis (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- loftool
- 0.0666
- rvis_EVS
- -1.15
- rvis_percentile_EVS
- 6.27
Haploinsufficiency Scores
- pHI
- 0.471
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.633
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.463
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tpp2
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein polyubiquitination;proteolysis
- Cellular component
- nucleoplasm;cytoplasm;cytosol;nuclear body
- Molecular function
- endopeptidase activity;aminopeptidase activity;serine-type endopeptidase activity;protein binding;tripeptidyl-peptidase activity;identical protein binding